Surgical Science Sweden AB (publ) (STO:SUS)
Sweden · Delayed Price · Currency is SEK 30.84
+0.64 (2.12%)
Jul 24, 2026, 5:29 PM CET
STO:SUS Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,574 | 1,658 | 7,955 | 9,312 | 8,367 | 14,301 | |
Market Cap Growth | -80.42% | -79.15% | -14.57% | 11.30% | -41.49% | 343.39% |
Enterprise Value | 908.07 | 1,042 | 6,987 | 8,678 | 7,933 | 13,984 |
Last Close Price | 30.84 | 32.50 | 155.90 | 182.50 | 164.70 | 281.50 |
PE Ratio | 30.14 | 24.81 | 60.43 | 39.76 | 44.63 | 139.36 |
Forward PE | 13.25 | 14.63 | 34.77 | 40.02 | 54.94 | 157.93 |
PEG Ratio | - | 1.74 | 1.74 | 1.74 | 1.74 | 1.74 |
PS Ratio | 1.61 | 1.67 | 9.00 | 10.55 | 10.43 | 38.99 |
PB Ratio | 0.36 | 0.39 | 1.65 | 2.14 | 1.97 | 3.99 |
P/TBV Ratio | 1.69 | 1.85 | 8.83 | 12.74 | 17.07 | 41.16 |
P/FCF Ratio | 12.00 | 24.35 | 60.67 | 40.87 | 69.65 | 406.13 |
P/OCF Ratio | 10.49 | 20.78 | 57.97 | 39.08 | 64.62 | 365.90 |
EV/Sales Ratio | 0.93 | 1.05 | 7.90 | 9.83 | 9.89 | 38.13 |
EV/EBITDA Ratio | 13.39 | 6.84 | 34.11 | 35.45 | 37.05 | 155.31 |
EV/EBIT Ratio | 13.39 | 15.13 | 48.41 | 45.88 | 48.81 | 247.40 |
EV/FCF Ratio | 6.92 | 15.30 | 53.29 | 38.09 | 66.04 | 397.13 |
Debt / Equity Ratio | 0.00 | 0 | 0 | 0 | 0 | 0 |
Debt / EBITDA Ratio | 0.03 | - | - | - | - | - |
Debt / FCF Ratio | 0.02 | - | - | - | - | - |
Net Debt / Equity Ratio | -0.15 | -0.14 | -0.20 | -0.15 | -0.10 | -0.09 |
Net Debt / EBITDA Ratio | -9.81 | -4.05 | -4.73 | -2.59 | -2.03 | -3.52 |
Net Debt / FCF Ratio | -5.07 | -9.05 | -7.38 | -2.78 | -3.61 | -8.99 |
Asset Turnover | 0.21 | 0.20 | 0.17 | 0.19 | 0.19 | 0.16 |
Inventory Turnover | 1.63 | 1.74 | 1.71 | 1.87 | 2.19 | 1.61 |
Quick Ratio | 3.22 | 2.82 | 2.24 | 3.25 | 2.05 | 1.93 |
Current Ratio | 4.44 | 4.05 | 2.78 | 4.22 | 2.70 | 2.65 |
Return on Equity (ROE) | 1.20% | 1.47% | 2.87% | 5.45% | 4.81% | 4.30% |
Return on Assets (ROA) | 0.99% | 0.90% | 2.36% | 3.53% | 3.40% | 3.33% |
Return on Invested Capital (ROIC) | 1.26% | 1.22% | 3.17% | 4.39% | 4.15% | 4.11% |
Return on Capital Employed (ROCE) | 1.52% | 1.47% | 3.06% | 4.29% | 4.02% | 2.70% |
Earnings Yield | 3.32% | 4.03% | 1.65% | 2.52% | 2.24% | 0.72% |
FCF Yield | 8.34% | 4.11% | 1.65% | 2.45% | 1.44% | 0.25% |
Buyback Yield / Dilution | - | 0.00% | -0.17% | -0.05% | -19.32% | -24.15% |
Total Shareholder Return | - | 0.00% | -0.17% | -0.05% | -19.32% | -24.15% |